Stock AnalizArgan Inc. AGX
Engineering & Construction · data as of November 13, 2026
Argan Inc. (AGX) is a consumer discretionary company listed in the US with a market value of about $4.3B. In the twelve months to July 31, 2026 it had revenue of $1.2B and net income of $179M, a net margin of 15.1%.
Its overall Stock Analiz score is 3.6 out of 5 (good). The strongest part is track record (5/5); the weakest is future growth (2/5).
Key numbers: a P/E of 24.2, a price to free cash flow of 7.9, 5-year revenue growth of 19% a year, a 5-year average ROIC of 15%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 110% above the current price.
Score: 3.6 / 5
Checks passed
- P/E below 25
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year revenue growth above 10% a year
- Profit margin improving
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
Checks not passed
- P/E below the industry median
- Revenue growth above 10% last year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- Liabilities below 60% of assets
- Share count down over 3 years (buybacks)
- 20% to 100% of free cash flow returned to shareholders
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2B | $945M | $874M | $573M | $455M | $509M | $392M | $239M | $482M | $893M | $675M |
| Net income | $179M | $138M | $85M | $32M | $33M | $38M | $24M | -$43M | $52M | $72M | $70M |
| Free cash flow | $546M | $411M | $161M | $114M | -$33M | $27M | $174M | $47M | -$121M | -$78M | $256M |
| EPS (diluted) | $12.64 | $9.74 | $6.15 | $2.39 | $2.33 | $2.40 | $1.51 | $-2.73 | $3.32 | $4.56 | $4.50 |
| Net margin | 15.1% | 14.6% | 9.8% | 5.6% | 7.3% | 7.5% | 6.1% | -17.9% | 10.8% | 8.1% | 10.4% |
| ROIC | — | 24.7% | 19.0% | 8.1% | 11.0% | 10.2% | 6.8% | -13.9% | 8.1% | 19.2% | 26.0% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 6 analysts is $570.50, 86% above the current price; targets range from $273.00 to $785.00; the consensus rating is “none”; expected EPS is $13.27 for the fiscal year ending January 31, 2027.
Frequently asked questions
What is Argan’s P/E ratio?
About 24.2, based on the last twelve months of diluted earnings per share (forward P/E about 21.2).
Is Argan stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 110% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Argan pay a dividend?
Yes. The dividend yield is about 0.87%, and it has paid dividends for 10 years in our data.
Is Argan a good stock to buy?
We do not give buy or sell advice. Argan scores 3.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.